Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA advisory committee rejects Amphotec supplemental NDA

April 21, 1997

Zagam available in Germany

April 18, 1997

ImmuCell to initiate clinical trial of DiffGAM

April 18, 1997

Morinaga Milk claims new antiparasitic agents

April 18, 1997

Isis receives contract for combinatorial antibacterial drug research

April 16, 1997

Use of desbutylhalofantrine for malaria claimed

April 15, 1997

Tentative approval for Faulding's generic aciclovir for injection

April 14, 1997

University of Michigan researchers describe anti-HCMV agents

April 14, 1997

Encouraging results from preclinical trial of Atlantic's RSV therapy

April 11, 1997

Hybridon selects HPV drug candidate

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...